Dexrazoxane is used to prevent cumulative cardiotoxicity caused by anthracycline use in adult or metastatic breast cancer. It prevents the binding of anthracyclines to the heart thus protecting the heart muscle.

It does not affect the efficacy of anthracycline based chemotherapy.